For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Younger Participants Hyperthermia Trial | Individuals aged 18-39 years Hyperthermia Trial: Individuals will be exposed to a controlled hyperthermia trial. | 0 | None | 0 | 12 | 0 | 12 | View |
| Older Participants Hyperthermia Trial | Individuals aged over 65 years Hyperthermia Trial: Individuals will be exposed to a controlled hyperthermia trial. | 0 | None | 0 | 9 | 1 | 9 | View |
| Younger Participants Control Trial | Individuals aged 18-39 years Control Trial: Individuals will be exposed to a control trial (no hyperthermia). | 0 | None | 0 | 11 | 0 | 11 | View |
| Older Participants Control Trial | Individuals aged over 65 years Control Trial: Individuals will be exposed to a control trial (no hyperthermia). | 0 | None | 0 | 9 | 0 | 9 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Syncope | SYSTEMATIC_ASSESSMENT | General disorders | None | View |